Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids

Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

(2013) A. Jahangiri et al.   CLINICAL CANCER RESEARCH

Integration of Different “-omics” Technologies Identifies Inhibition of the IGF1R-Akt-mTOR Signaling Cascade Involved in the Cytotoxic Effect of Shikonin against Leukemia Cells

(2013) Benjamin Wiench et al.   Evidence-based Complementary and Alternative Medicine

Orally Inhaled Dihydroergotamine: A Review

(2013) Stewart J. Tepper   HEADACHE

Which Uterotonic Is Better to Prevent the Postpartum Hemorrhage? Latest News in Terms of Clinical Efficacy, Side Effects, and Contraindications

(2013) Salvatore Gizzo et al.   Reproductive Sciences

COMPARE analysis of the toxicity of an iminoquinone derivative of the imidazo[5,4-f]benzimidazoles with NAD(P)H:quinone oxidoreductase 1 (NQO1) activity and computational docking of quinones as NQO1 substrates

(2012) Vincent Fagan et al.   BIOORGANIC & MEDICINAL CHEMISTRY

CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set

(2012) W. C. Reinhold et al.   CANCER RESEARCH

Signal Transduction Pathways of the Epidermal Growth Factor Receptor in Colorectal Cancer and their Inhibition by Small Molecules

(2012) T. Efferth   CURRENT MEDICINAL CHEMISTRY

Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N’-substituted ureas with pharmacophoric moieties

(2012) Elena L. Luzina et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Cytotoxicity and Fluorescence Visualization of Ergot Alkaloids in Human Cell Lines

(2012) Dennis Mulac et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

The Chemistry of Peptidyltransferase Center-Targeted Antibiotics: Enzymatic Resistance and Approaches to Countering Resistance

(2011) Kevin P. McCusker et al.   ACS Chemical Biology

RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis

(2011) Barry R Zeeberg et al.   BMC BIOINFORMATICS

Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives

(2011) Serkan Sertel et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin

(2011) Thomas Efferth et al.   PHYTOMEDICINE

Cytotoxicity and accumulation of ergot alkaloids in human primary cells

(2011) Dennis Mulac et al.   TOXICOLOGY

Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy

(2010) Thomas Efferth et al.   CURRENT DRUG TARGETS

The role of mutant p53 in human cancer

(2010) Amanda M Goh et al.   JOURNAL OF PATHOLOGY

Acting Locally and Globally: Myc's Ever-Expanding Roles on Chromatin

(2009) N. V. Varlakhanova et al.   CANCER RESEARCH

Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line

(2009) Joanne Keenan et al.   PROTEOMICS

Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen

(2008) S. A. Amundson et al.   CANCER RESEARCH

Prediction of Broad Spectrum Resistance of Tumors towards Anticancer Drugs

(2008) T. Efferth et al.   CLINICAL CANCER RESEARCH